首页> 外文期刊>Hepato-gastroenterology. >Is resection for large hepatocellular carcinoma in cirrhotic patients beneficial? Study of 38 cases.
【24h】

Is resection for large hepatocellular carcinoma in cirrhotic patients beneficial? Study of 38 cases.

机译:肝硬化患者大肝癌切除术有益吗?研究38例。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND/AIMS: Hepatocellular carcinoma in cirrhotic patients generally carries a poor prognosis either due to recurrence or to postoperative morbidity or both. Several factors affect the prognosis of hepatocellular carcinoma resection as presence of cirrhosis of the liver, tumor diameter and tumor capsulation. METHODOLOGY: Thirty-eight patients with large hepatocellular carcinoma greater than 5 cm with a background of cirrhotic liver were divided into two groups according to tumor diameter. Group A (n = 20) with tumors less than 10 cm in diameter, and group B (n = 18) with tumors larger than 10 cm. All patients underwent preoperative investigations including clinical laboratory tests, sonography, computed tomography, selective angiography and upper gastrointestinal endoscopy. All patients were subjected to different types of hepatic resection. RESULTS: A significant difference in tumor size, capsulation, and operation time were recorded between the two groups, of patients. No significant difference was detected between both groups regarding sex, age, viral markers, pathologic features, and Child classification. Hospital mortality occurred in 5% versus 11.1% of both groups, respectively. Postoperative jaundice and ascitis occurred in 30%, 35% versus 44.4%, 72.0%, respectively (P < 0.005, P < 0.04). Late mortality occurred in 65% of patients in group A and in 77% of group B. Recurrence was detected in 42% of group A and 62% in group B. Recurrence after resection in capsulated tumors was significantly lower than in noncapsulated tumors in group A (P < 0.01), but not significant in group B. Also, survival rate in patients with capsulated tumors was significantly better in both groups (P < 0.01) than that with noncapsulated tumors. CONCLUSIONS: Resection of hepatocellular carcinoma with diameter larger than 10 cm recorded bad prognosis regarding recurrence and mortality rates than tumors less than 10 cm. However, capsulated tumors gave better postoperative prognosis than noncapsulated ones.
机译:背景/目的:肝硬化患者的肝细胞癌一般由于复发或术后发病或二者兼有而预后较差。肝硬化,肿瘤直径和肿瘤包囊的存在会影响肝细胞癌切除术的预后。方法:将38例大于5 cm且有肝硬化背景的大肝细胞癌患者根据肿瘤直径分为两组。 A组(n = 20)的肿瘤直径小于10 cm,B组(n = 18)的肿瘤直径大于10 cm。所有患者均接受术前检查,包括临床实验室检查,超声检查,计算机断层扫描,选择性血管造影和上消化道内窥镜检查。所有患者均接受了不同类型的肝切除术。结果:两组患者的肿瘤大小,包囊和手术时间均存在显着差异。两组在性别,年龄,病毒标记,病理特征和儿童分类方面均未发现显着差异。两组的住院死亡率分别为5%和11.1%。术后黄疸和腹膜炎的发生率分别为30%,35%和44.4%,72.0%(P <0.005,P <0.04)。晚期死亡率发生在A组的65%的患者和B组的77%的患者中。A组的42%和B组的患者检出了复发。囊性肿瘤切除后的复发率显着低于非囊性肿瘤A(P <0.01),但在B组中不显着。而且,包膜肿瘤患者的生存率在两组中均显着好于P(0.01)。结论:直径大于10 cm的肝细胞癌切除术后复发和死亡率的预后较10 cm以下的肿瘤差。但是,包膜的肿瘤比非包膜的肿瘤具有更好的术后预后。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号